Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 1.01
-9.82 %
$ 31.3 M
Market Cap
-1.66
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
102.81%
EBIT
Estimate
--33.42%
Net Income
Estimate
46.77%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
DURECT Corporation
DRRX has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart DRRX
EBIT FORECAST
EBIT Forecast Chart DRRX
NET INCOME FORECAST
Net Income Chart DRRX